Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma

Published 2015 View Full Article

Authors

Keywords

Indomethacin, Hepatocellular carcinoma, TNF-α, IFN-γ, PD-1/PD-L2 pathway, TRIF/NF-κB

Journal

EXPERIMENTAL CELL RESEARCH

Volume 337, Issue 1, Pages 53-60

Publisher

Elsevier BV

Online

2015-07-08

DOI

10.1016/j.yexcr.2015.07.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now